Current Issue

View Larger Image

Past Issues Free Subscriptions
Sponsored
Keywords



Search Results - Bayer
 More »

  • Bayer Prostate Cancer Drug Gains FDA Approval
    Bayer HealthCare said yesterday it is weeks away from joining Algeta in bringing to the ... Bayer HealthCare and Algeta will co-promote Xofigo in the U.S, with Bayer holding ...
    5-16-2013
  • Companion Diagnostics: 52 Pick-Up
    ... Qiagen and Bayer HealthCare Agreement announced October 25, 2012 Collaboration where ... therapies developed by Bayer HealthCare, which are currently in early development." ...
    5-9-2013
  • Regeneron Gains Full Rights to Ophthalmology Antibodies from...
    The PDGF and ANG2 antibody families fit with one of Regeneron's areas of disease focus, eye disorders. In November 2011, the company joined Bayer HealthCare in launching the ...
    5-3-2013
  • The Globalization of IVD Companies
    share. In 2012, their share grew to 63%. The second tier group containing Alere, Bayer Diabetes Care Division, bioMerieux, Sysmex, and Becton, Dickinson and Co. also expanded ...
    5-1-2013
  • Hormone Holds Promise for Replacing Insulin Injections
    ... In addition to CureBeta, Evotec has long-term discovery alliances with partners that include Bayer, Boehringer Ingelheim, CHDI, Genentech, MedImmune/AstraZeneca, and Ono ...
    4-26-2013
  • GEN | Biolinks
    Tertiary Education Austrian Biotech Industry Bavarian Nordic Bay Path College BayBio Bayer Healthcare Pharmaceuticals BD Biosciences (CA) Beckman Coulter (Products) Beckman ...
  • Bayer, KeyGene Partner to Improve Agricultural Crops
    Bayer CropScience and KeyGene today announced that they have entered a multiyear R&D ... From there, Bayer intends to introduce new crop varieties based on global seed market ...
    4-24-2013
  • Top 20 Best-Selling Drugs Approved and Launched During 2012
    ... (regorafenib) 2012 sales: $41.4 million (€32 million) 12,13 Marketer(s): Bayer HealthCare and Onyx Pharmaceuticals Indication(s): Metastatic colorectal cancer in ...
    4-4-2013
  • AstraZeneca Idling Another 2,300; Unveils Comeback Strategy
    ... The higher risk, Fitch said, stems from less stable revenue streams in pharma vs. generics or OTC. "As opposed to its more diversified European peers GlaxoSmithKline, Bayer, ...
    3-21-2013
  • Bayer Taps ChromoTek's Drug Profiling Technology
    Bayer Pharma has gained the right to use ChromoTek's Cell Cycle Chromobody® technology for drug profiling by high-content analysis. Bayer will apply Chromobody technology for ...
    3-18-2013
  • Big Pharma Loses Another Leader: Roche Chairman to Retire
    Jörg Reinhardt, Ph.D., former CEO of Bayer Healthcare, will be Novartis' new chairman beginning August 1. Long-time Roche chairman Franz B. Humer has decided not to run for ...
    3-5-2013
  • Adderall Generics and Legal Woes Hurt Shire
    ... Russell, who has served as CEO since 2008, will retire in May and be succeeded by Flemming Ornskov, who joined Shire in January from Bayer, where he served as chief marketing ...
    2-14-2013
  • Nuvilex Lights Up New Medical Marijuana Company
    In June 2010, GW Pharmaceuticals and Bayer Schering Pharma launched Sativex -an oromucosal spray discovered and developed by GW Pharmaceuticals, and the first cannabinoid medicine ...
    2-12-2013
  • Consortium Launches €196M Drug Discovery "Factory"
    Merck and the other six pharmas-AstraZeneca, Bayer, Johnson & Johnson-owned Janssen Pharmaceutica, Lundbeck, Sanofi, and UCB Pharma-will contribute "at least" 300,000 chemical ...
    2-7-2013
  • People in the News
    ... Additionally, he has held management positions at Becton Dickinson, Bayer Diagnostics, Ortho Diagnostic Systems, and Abbott Laboratories. David Tran joined PAC as vp of product ...
    2-1-2013
  • More »

    Journal Articles

  • Wound Repair Potential of Olea europaea L. Leaf Extracts Revealed...
    Ufuk Koca, Ipek Süntar, Esra Küpeli Akkol, Demet Yilmazer, Murat Alper
    Journal of Medicinal Food
    wound healing activity by using in vivo wound models of linear incision and circular excision in comparison with the reference ointment Madecassol® (Bayer, Istanbul, Turkey). ...
  • Performance of a New Blood Glucose Monitoring System in the Hands...
    Timothy S. Bailey, Jane F. Wallace, Joan Lee Parkes, Scott Pardo, Ji Yu, Holly C. Schachner, David A. Simmons, Amy Chu
    Diabetes Technology & Therapeutics
    Untrained subjects performed self-test fingersticks using a Microlet®2 lancing device (Bayer HealthCare LLC, Diabetes Care, Tarrytown, NY) followed by testing of their own ...
  • The Accuracy of Home Glucose Meters in Hypoglycemia
    Alper Sonmez, Zeynep Yilmaz, Gokhan Uckaya, Selim Kilic, Serkan Tapan, Abdullah Taslipinar, Aydogan Aydogdu, Mahmut Yazici, Mahmut Ilker Yilmaz, Muhittin Serdar, M. Kemal Erbil, Mustafa Kutlu
    Diabetes Technology & Therapeutics
    We evaluated the accuracy and the capillary and venous comparability of five different HGMs (Optium Xceed(tm) [Abbott Diabetes Care, Alameda, CA, USA], Contour® TS [Bayer Diabetes ...
  • Accuracy Evaluation of Five Blood Glucose Monitoring Systems...
    Cornelius Tack, Harald Pohlmeier, Thomas Behnke, Volkmar Schmid, Marco Grenningloh, Thomas Forst, Andreas Pfützner
    Diabetes Technology & Therapeutics
    [LifeScan Inc., Milpitas, CA], Accu-Chek® Aviva [Roche Diagnostics, Mannheim, Germany], and Contour® [Bayer Vital GmbH, Leverkusen, Germany]) in a daily routine setting. ...

GEN Webinars

View »

GEN Web Briefs

View »

GEN Poll

More » Poll Results » Archive »

Genome Sequencing and Patient Autonomy

Do you think ACMG’s recent recommendations for reporting incidental clinical sequencing results undermine patient autonomy?

Suggest a Poll